Table 1. Relationship of the Expression of ISG15 and Clinicopathological Feature of HCC.
Parameter | Groups | Number of Patient | ISG15 Relative Expression | P |
---|---|---|---|---|
Age(yr) | ≥50 | 19 | 0.92±0.14 | 0.764 |
<50 | 31 | 0.84±0.09 | ||
Gender | Male | 44 | 0.85±0.08 | 0.456 |
Female | 6 | 0.86±0.22 | ||
HBV infection | Postive | 46 | 0.89±0.08 | 0.555 |
Negative | 4 | 1.07±0.38 | ||
AFP(ng/ml) | ≥400 | 27 | 0.87±0.11 | 0.394 |
<400 | 23 | 0.93±0.12 | ||
Tumor size(cm) | ≥5 | 29 | 0.88±0.12 | 0.680 |
<5 | 21 | 0.84±0.09 | ||
Tumor number | Single | 39 | 0.86±0.09 | 0.210 |
Multiple | 11 | 1.22±0.13 | ||
Differentiation | Moderate to well | 33 | 0.54±0.06 | <0.001* |
Poor | 17 | 1.34±0.20 | ||
Portal vein tumor thrombus | Positive | 3 | 1.01±0.40 | 0.685 |
Negative | 47 | 0.86±0.08 | ||
Metastasis | Positive | 22 | 1.12±0.10 | 0.001* |
Negative | 28 | 0.68±0.11 |